These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3429869)

  • 1. Renal effects of nicardipine in essential hypertension: differences between acute and chronic therapy.
    Smith SA; Rafiqi EI; Gardener EG; Young MA; Littler WA
    J Hypertens; 1987 Dec; 5(6):693-7. PubMed ID: 3429869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic (systemic and renal) and humoral interactions between nicardipine and domperidone in hypertensives.
    Lucarini AR; Salvetti A
    J Hypertens Suppl; 1987 Dec; 5(5):S571-4. PubMed ID: 3327930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple oral doses of nicardipine, a calcium-entry blocker: effects on renal function, plasma renin activity, and aldosterone concentration in mild-to-moderate essential hypertension.
    Baba T; Ishizaki T; Murabayashi S; Aoyagi K; Tamasawa N; Takebe K
    Clin Pharmacol Ther; 1987 Aug; 42(2):232-9. PubMed ID: 3301155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of a new calcium inhibitor, nicardipine, on renal hemodynamics in hypertension.
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guedon J
    J Cardiovasc Pharmacol; 1986; 8(5):892-7. PubMed ID: 2429087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
    Baba T; Murabayashi S; Takebe K
    Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of diltiazem in primary hypertension.
    Sunderrajan S; Reams G; Bauer JH
    Hypertension; 1986 Mar; 8(3):238-42. PubMed ID: 3949375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
    Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
    Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a calcium-entry blocker, nicardipine, on intrarenal hemodynamics in essential hypertension.
    Kimura G; Deguchi F; Kojima S; Ashida T; Yoshimi H; Abe H; Kawano Y; Yoshida K; Kawamura M; Imanishi M
    Am J Kidney Dis; 1991 Jan; 17(1):47-54. PubMed ID: 1986570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T; Marion DN; Camargo MJ; Kleinert HD; Laragh JH; Vaughan ED; Atlas SA
    Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the renal haemodynamic and natriuretic effects of calcium antagonists and angiotensin converting inhibitors additive?
    Natov S; Hannedouche T; Schmitt F; Ikeni A; Déchaux M; Kirkisseli S; Lacour B; Grünfeld JP
    J Hypertens Suppl; 1991 Dec; 9(6):S392-3. PubMed ID: 1819003
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy.
    Baba T; Tomiyama T; Murabayashi S; Takebe K
    Eur J Clin Pharmacol; 1990; 38(5):425-9. PubMed ID: 2379527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension.
    Baba T; Boku A; Ishizaki T; Sone K; Takebe K
    Am Heart J; 1986 Mar; 111(3):552-7. PubMed ID: 3953366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of nicardipine, a calcium entry blocker, in hypertensive type II diabetic patients with nephropathy.
    Baba T; Ishizaki T; Ido Y; Aoyagi K; Murabayashi S; Takebe K
    Diabetes; 1986 Nov; 35(11):1206-14. PubMed ID: 3530849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a calcium channel blocker, nicardipine, on pressure-natriuresis in Dahl salt-sensitive rats.
    Takenaka T; Suzuki H; Ikenaga H; Itaya Y; Yamakawa H; Sakamaki Y; Saruta T
    Clin Exp Hypertens; 1994 Jan; 16(1):77-88. PubMed ID: 8136777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
    van Paassen P; de Zeeuw D; de Jong PE
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):39-45. PubMed ID: 7564363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cromakalim on renal hemodynamics and function in dogs: comparison with nicardipine.
    Tamaki T; Hasui K; Shoji T; Fukui K; Iwao H; Abe Y
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):305-9. PubMed ID: 1709236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of slow-release nicardipine on blood pressure, renal function and the renin-angiotensin-aldosterone system in patients with mild-to-moderate essential arterial hypertension].
    Melina D; Guerrera G; Santoliquido A; Colivicchi F; Melina G; Musumeci V; Guerrera C
    Clin Ter; 1991 Nov 15-30; 139(3-4):101-6. PubMed ID: 1837249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.